Tech Company Financing Transactions
Rakuten Medical Funding Round
Rakuten Medical, based in San Mateo, scored $166 million from General Catalyst Partners and private investors.
Transaction Overview
Company Name
Announced On
8/2/2021
Transaction Type
Venture Equity
Amount
$166,000,000
Round
Series D
Investors
General Catalyst Partners (Lead Investor) (Paul Kwan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
900 Concar Dr.
San Mateo, CA 94402
USA
San Mateo, CA 94402
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Rakuten Medical, Inc. is a global biotechnology company developing precision, cell-targeting investigational therapies on its Illuminox technology platform which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Illuminox therapies have not yet been approved as safe or effective by any regulatory authority.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mickey Mikitani
Chief Operating Officer
Brenton Keath
Chief Scientific Officer
Miguel Garcia-Guzman
Chief Technical Officer
Carlos Garcia
President
Takashi Toraishi
Vice President
Jeffrey Berry
VP - Bus. Development
Abhijit Bhatia
VP - Bus. Development
Tomasz Zastawny
VP - Finance
Agatha Martindale
VP - General Counsel
Annie Mcguire
VP - Human Resources
Suzane San
VP - Regulatory Affairs
Doreen Gousset
VP - Regulatory Affairs
Shawn Schaffer
Browse more venture capital transactions:
Prev: 8/2/2021: Bota Biosciences venture capital transaction
Next: 8/2/2021: Lucid Drone Technologies venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs